Biotech Startups

Peptinovo develops PALM™, a targeted drug-delivery platform that encapsulates chemotherapy drugs to deliver them directly to cancer cells while sparing healthy tissue, reducing side effects and enabling higher therapeutic doses. The technology mimics HDL cholesterol carriers that cancer cells naturally uptake, allowing selective destruction of tumors with improved safety profiles.

2 investors

Peptron is a Korean pharmaceutical company that develops sustained-release injectable drug formulations using its proprietary SmartDepot ultrasonic spray drying technology to create long-acting microsphere formulations. It operates a GMP-designed manufacturing facility producing SR-exenatide and is developing exenatide as a treatment for neurodegenerative disorders under licensed NIH patents.

2 investors

Perceptic builds an AI platform that unifies evidence, data, and decision workflows across the drug development lifecycle, connecting asset scouting, scientific evaluation, and clinical data on a shared intelligence layer. It targets pharmaceutical and drug development organizations, providing traceable, data-backed decision-making with AI-assisted reasoning.

2 investors

Perception Medicine develops AI-driven precision oncology solutions for cancer patients. The company's team combines expertise in artificial intelligence, clinical medicine, and product design, with roots in Stanford and MIT research.

2 investors

Perception Neuroscience is a clinical-stage biotech developing R-ketamine (PCN-101), a single-isomer glutamatergic modulator being studied as a rapid-acting antidepressant for patients with treatment-resistant depression. The company licenses intellectual property originally discovered at Chiba University and is running a Phase 2a proof-of-concept clinical trial.

2 investors

Peregrine is a global life science venture capital fund that invests in healthcare companies through strategic synergistic investments. The firm partners with entrepreneurs and established healthcare institutions to develop innovations that improve health outcomes and healthcare economics.

2 investors

Perfectly Dosed supplies nanoemulsion cannabinoid ingredients that allow manufacturers to infuse consistent, precise doses into their products. It provides full-service support and scalable pricing for product makers of varying sizes.

2 investors

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.

2 investors

PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.

2 investors

PerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications. The company operates globally with a focus on enabling scientific discovery and sustainability.

2 investors

Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status. Its lead product is CE Marked in the European Union but not FDA cleared in the United States.

2 investors

Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.

2 investors

Brandon Capital is a venture capital firm that transforms medical research breakthroughs into therapeutic products, supporting life science companies from early-stage through commercialization. The firm operates across Australia, New Zealand, and globally, with a focus on building a sustainable biotech industry.

2 investors

Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid. It develops devices and technology in the neurology and brain health category.

2 investors

PharmaCann is a vertically integrated cannabis company operating cultivation centers, product brands, and retail dispensaries (LivWell and Verilife) serving both medical patients and recreational customers in the United States. It develops and sells cannabis products across the wellness-focused cannabis industry.

2 investors

Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.

2 investors

Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute. The company focuses on translating scientific discoveries into clinical therapies for patients.

2 investors

Phenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs. Its platform-based approach targets the healthcare market for obesity treatment.

2 investors

Pheon Therapeutics develops targeted oncology treatments, focusing on antibody-drug conjugates (ADCs) for cancer therapy.

2 investors

Pheronym develops nematode pheromone technology that directs nematode behavior to control agricultural pests. Its products combine pheromones with beneficial nematodes to create bee-safe biopesticides and repel plant-parasitic nematodes for crop protection.

2 investors

PhiTech is a TechBio company that develops AI-powered multi-omics diagnostic platforms for rare diseases and hereditary cancers. The company serves hospitals, laboratories, and pharmaceutical companies seeking to improve diagnosis and treatment decisions for complex genetic conditions.

2 investors

Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.

2 investors

PhosPrint develops bioprinters designed to print bio-inks for tissue engineering applications. The company's Dual Beam I system combines printing and post-processing capabilities for cellular constructs.

2 investors

PhotoPharmics is a clinical-stage medical device company developing non-invasive, light-based photo-neuromodulation therapies for neurodegenerative disease, with a focus on Parkinson's disease. Its investigational device Celeste delivers light through the eyes at home and is being evaluated in clinical trials targeting non-motor symptoms such as sleep, fatigue, and mood.

2 investors